US Map / Rhode Island
State RI

Clinical Trials in Rhode Island

Rhode Island is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Rhode Island and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 65 actively recruiting studies with Rhode Island sites out of 65 registered in total. The busiest research areas in Rhode Island are Ulcerative Colitis, Diabetic Peripheral Neuropathic Pain, Pulmonary Hypertension. Leading sponsors running trials in the state include Brown University, National Cancer Institute (NCI), Pfizer. By stage, Rhode Island trials break down as Phase 1 (5), Phase 2 (11), Phase 3 (19), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
65
Recruiting Now
65
← Back to US Map
Top Conditions in Rhode Island
Ulcerative Colitis (3)Diabetic Peripheral Neuropathic Pain (2)Pulmonary Hypertension (2)COVID-19 (2)Obesity (2)Solid Tumor (2)Ovarian Cancer (2)Healthy (1)Pareses (1)Lower Extremity (1)Multiple Myeloma (1)Pelvic Organ Prolapse (1)

Frequently Asked Questions — Clinical Trials in Rhode Island

How many clinical trials are currently recruiting in Rhode Island?
ClinicalMetric currently tracks 65 actively recruiting clinical trials with at least one location in Rhode Island. The total number of registered studies—including active but not currently enrolling trials—is 65. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Rhode Island?
Rhode Island hosts clinical trials across a broad range of medical conditions, including Ulcerative Colitis, Diabetic Peripheral Neuropathic Pain, Pulmonary Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Rhode Island serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Rhode Island?
To join a clinical trial in Rhode Island, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Rhode Island maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Rhode Island

NCT06850623 Phase 2
Recruiting
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Ad...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
25 pts
Location
United States, United Kingdom
Sponsor
EXACT Therapeutics AS
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT07546929 Phase 2
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Di...
Condition
Type 2 Diabetes
Enrollment
300 pts
Location
United States
Sponsor
Housey Healthcare ULC
View Trial →
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
216 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06822569 N/A
Recruiting
Teen Health Choices & Wellness
Condition
Health Behavior
Enrollment
224 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT07218237 N/A
Recruiting
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnan...
Condition
Preeclampsia
Enrollment
90 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06641466 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used f...
Condition
Menstrual Migraine
Enrollment
723 pts
Location
United States, Argentina, Canada
Sponsor
Pfizer
View Trial →
NCT07195019 N/A
Recruiting
Women's Wellbeing Study
Condition
Distress, Psychological
Enrollment
48 pts
Location
United States
Sponsor
Butler Hospital
View Trial →
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
View Trial →
NCT05765851 Phase 1
Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumo...
Condition
Advanced Solid Tumor
Enrollment
128 pts
Location
United States, Canada, France
Sponsor
Daiichi Sankyo
View Trial →
NCT07113522 Phase 2
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Condition
Inflammatory Bowel Disease (IBD)
Enrollment
140 pts
Location
United States, Canada, Georgia
Sponsor
Mirador Therapeutics, Inc.
View Trial →
NCT07713251 N/A
Recruiting
Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills T...
Condition
Alcohol Use Disorder
Enrollment
112 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT06937086 Phase 3
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants W...
Condition
Ulcerative Colitis
Enrollment
350 pts
Location
United States, Austria, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT05261139 Phase 3
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatr...
Condition
COVID-19
Enrollment
160 pts
Location
United States, Bulgaria, Japan
Sponsor
Pfizer
View Trial →
Page 3 of 3 — 65 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology